Gluten-Free vs Mediterranean Diet in Rheumatoid Arthritis

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a 12-week dietary intervention study in adults with rheumatoid arthritis. Participants are assigned to one of three diet arms: gluten-free, Mediterranean, or a control diet. The trial will measure disease activity with the DAS28, quality of life with SF-12, and dietary inflammatory index from dietary data collected during the study. Changes in clinical and nutritional outcomes will be analyzed to see if dietary patterns influence RA progression and patient well-being.

Why it matters

Who can join: the full rules

Inclusion Criteria:

Diagnosis of rheumatoid arthritis according to ACR/EULAR criteria Age between 19-65 years Stable medication regimen for at least 3 months prior to enrollment Willingness to comply with dietary interventions and study procedures Ability to provide informed consent

Exclusion Criteria:

Pregnancy or lactation Presence of other autoimmune or inflammatory diseases (e.g., SLE, IBD) Severe comorbidities (e.g., advanced cardiovascular, renal, or hepatic disease) Use of special diets (e.g., gluten-free diet) in the last 3 months Recent change in biologic or corticosteroid therapy (\<3 months) Food allergies or intolerances affecting dietary intervention adherence Inability to comply with dietary protocol or follow-up visits

Where it's running

• NCR International Hospital
  Gaziantep, Şehitkamil, Turkey (Türkiye) Recruiting

Study contacts

• Study coordinator: Nilüfer Gürsel, PhD
• Email: nilufergursell@gmail.com
• Phone: +90 506 379 73 42

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Heart Rate Variability and Rheumatoid Arthritis: What HRV Looks Like with RA

  This study checks whether continuous HRV data from an Oura ring can reflect RA disease activity in adults with RA.

  Recruiting University of Central Florida · Orlando, Florida · NCT07878975

• Discontinuing MTX or LEF in RA Patients on TNF Inhibitors

  This trial tests whether stopping methotrexate or leflunomide while continuing a TNF inhibitor is not worse for disease control in adults with rheumatoid arthritis.

  Recruiting Phase 4 Sint Maartenskliniek · Nijmegen, Gelderland and 3 other locations · NCT07802678

• FT839 therapy for autoimmune diseases

  This trial tests FT839, given alone or with rituximab, to see if it is safe and can help people with certain autoimmune diseases who have not responded to other treatments.

  Recruiting Phase 1/2 Fate Therapeutics · Fullerton, California · NCT07800871

• 24-Hour Movement and Atherosclerotic Risk in adults with rheumatoid arthritis

  This study tests how daily activity, sitting, and sleep relate to heart-related risk in adults with RA, using wearables and follow-up after a year.

  Recruiting São Paulo State University · Presidente Prudente, São Paulo · NCT07774507

• Integrative AI profiling of chronic RA pain

  This study tests whether an AI-driven multiomic and neurophysiological approach can help explain and predict persistent pain in adults with active rheumatoid arthritis.

  Recruiting 4th Military Clinical Hospital with Polyclinic, Poland · Wroclaw · NCT07769619

• Oxidative Stress and Heart Risk in People with Rheumatoid Arthritis

  This study tests whether certain markers of oxidative stress in people with rheumatoid arthritis are linked to subclinical atherosclerosis and arterial stiffness, which could relate to future heart disease risk.

  Recruiting University of La Laguna · Santa Cruz de Tenerife, Canary Islands · NCT07760662

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.